Last updated on March 2017

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine


Brief description of study

Comparing Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of TEV-48125 Versus Placebo for the Preventive Treatment of Chronic Migraine

Detailed Study Description

The study is being conducted to evaluate two doses of TEV-48125 in adult patients with episodic migraine

Clinical Study Identifier: TX148093

Contact Investigators or Research Sites near you

Start Over

Patient Recruitment

Cedar Crosse Research Center
Chicago, IL USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.